Some human and animal preclinical trials studying several angiogenic growth factors including VEGF, FGF, HGF, PDGF, and HIF have shown increased capillary growth, increased myocardial perfusion, and improved exercise capacity in participants with coronary artery disease (CAD) [123,124,125,126]. Here, HGF is linked to coronary artery disorder.